Method for Predicting Treatment Effects of EGFR Inhibitor in Glioblastoma

摘要

The present invention relates to a method for predicting the effectiveness of a therapeutic effect on an epidermal growth factor receptor (EGFR) inhibitor, and more particularly, the present invention relates to a method for predicting the efficacy of a new genome sequencing (NGS) (EGFR) copy number was measured in the DNA collected from the subject, and the sensitivity to the therapeutic effect of the EGFR inhibitor was significantly high according to the number of EGFR copies. Thus, the EGFR (epidermal growth factor receptor can be usefully used as a method for predicting the effectiveness of a therapeutic effect on a subject.